On March 14, 2022, Akebia Therapeutics was sued for violations of the federal securities laws in the United States District Court for the Eastern District of New York on behalf of investors who purchased the Company’s securities between June 28, 2018 and September 2, 2020.
We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.